BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16012951)

  • 21. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells.
    Bataller R; Paik YH; Lindquist JN; Lemasters JJ; Brenner DA
    Gastroenterology; 2004 Feb; 126(2):529-40. PubMed ID: 14762790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes.
    Cheng JC; Tseng CP; Liao MH; Peng CY; Yu JS; Chuang PH; Huang JT; Chen JJW
    Sci Rep; 2017 Jun; 7(1):4448. PubMed ID: 28667290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication.
    Florimond A; Chouteau P; Bruscella P; Le Seyec J; Mérour E; Ahnou N; Mallat A; Lotersztajn S; Pawlotsky JM
    Gut; 2015 Jun; 64(6):957-65. PubMed ID: 25063678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
    Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
    Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C.
    Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A
    Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells.
    Jung GS; Jeon JH; Choi YK; Jang SY; Park SY; Kim MK; Shin EC; Jeong WI; Lee IK; Kang YN; Park KG
    Liver Int; 2015 Oct; 35(10):2233-45. PubMed ID: 25976932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.
    Roulot D; Sevcsik AM; Coste T; Strosberg AD; Marullo S
    Hepatology; 1999 Jun; 29(6):1730-8. PubMed ID: 10347115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.
    Kornek M; Popov Y; Libermann TA; Afdhal NH; Schuppan D
    Hepatology; 2011 Jan; 53(1):230-42. PubMed ID: 20979056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV increases HCV replication in a TGF-beta1-dependent manner.
    Lin W; Weinberg EM; Tai AW; Peng LF; Brockman MA; Kim KA; Kim SS; Borges CB; Shao RX; Chung RT
    Gastroenterology; 2008 Mar; 134(3):803-11. PubMed ID: 18325393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals.
    Ikejima K; Honda H; Yoshikawa M; Hirose M; Kitamura T; Takei Y; Sato N
    Hepatology; 2001 Aug; 34(2):288-97. PubMed ID: 11481614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model.
    Sasaki R; Devhare P; Ray RB; Ray R
    Hepatology; 2017 Dec; 66(6):1766-1778. PubMed ID: 28664988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo.
    Zhan SS; Jiang JX; Wu J; Halsted C; Friedman SL; Zern MA; Torok NJ
    Hepatology; 2006 Mar; 43(3):435-43. PubMed ID: 16496318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrogenic Gene Expression in Hepatic Stellate Cells Induced by HCV and HIV Replication in a Three Cell Co-Culture Model System.
    Akil A; Endsley M; Shanmugam S; Saldarriaga O; Somasunderam A; Spratt H; Stevenson HL; Utay NS; Ferguson M; Yi M
    Sci Rep; 2019 Jan; 9(1):568. PubMed ID: 30679661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling.
    Meurer SK; Tihaa L; Borkham-Kamphorst E; Weiskirchen R
    Cell Signal; 2011 Apr; 23(4):683-99. PubMed ID: 21146604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells.
    Wobser H; Dorn C; Weiss TS; Amann T; Bollheimer C; Büttner R; Schölmerich J; Hellerbrand C
    Cell Res; 2009 Aug; 19(8):996-1005. PubMed ID: 19546889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
    Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
    Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.